| The George Washington University, MS | 1972 |
| Biomedical Engineering | |
| University of Miami, BS | |
| Electrical Engineering |
Rudy Rodriguez, Chief Scientific Officer and founder of AAD, has more than 30 years of experience in developing medical devices. Before starting AAD he served for 15 years as the vice president of research & development for Becton Dickinson (BD) Primary Care Diagnostics Division, and prior to that he worked in senior research and engineering positions at Coulter Corporation (now Beckman Coulter), Baxter Corporation, and American Instrument Company (Aminco).
Rodriguez has a reputation as an R&D pioneer. He has been involved in the development and commercialization of several products in his career that created entirely new industry segments or sold more than $1 billion each. Among them are the first automated blood cell separator at Baxter (Fenwal CS-3000), the first random access chemistry analyzer (the Coulter DACOS) and the world’s most successful physician’s office hematology system at BD (the QBC). He subsequently adapted the QBC technology into the VetAutoread Hematology Analyzer, marketed by IDEXX for companion animal use. While at American Instrument, he participated in the development of the Aminco SPF and the Aminco DW-2, famed scientific instruments which enabled the biotech industry by allowing measurement of minute biochemical changes in-vitro.
Rudy holds 28 patents and is a four-time winner of the R&D 100 Award for one of the 100 most significant new technical products of the year. He is currently an adjunct professor at North Carolina State University’s College of Veterinary Medicine.
